Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Just FYI, Resverlogix highlighted the CANTOS trial results for the anti-IL1B antibody canakinumab in a news release last August and pointed out the anti-inflammatory properties of apabetalone.
